CCA
MDT icon

Catalyst Capital Advisors’s Medtronic MDT Stock Holding History

Catalyst Capital Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-35
Closed -$12K – 463
2017
Q3 		$12K Hold
35
– – ﹤0.01% 351
2017
Q2 		$34K Hold
35
– – ﹤0.01% 331
2017
Q1 		$23K Buy
+35
New +$2.73K ﹤0.01% 359
2016
Q4 		– Sell
-200
Closed -$27K – 474
2016
Q3 		$27K Buy
+200
New +$17.4K ﹤0.01% 342

Other funds holding MDT

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Catalyst Capital Advisors's MDT Position: Q2 2026 in Review

Catalyst Capital Advisors held its Medtronic (MDT) position steady in Q2 2026 at 30,550 shares worth $2.39M. The position accounts for 0.04% of the portfolio, ranked #104.

Catalyst Capital Advisors first reported a position in MDT in Q2 2013 and has held it in 24 quarters since. The position peaked at $7.13M in Q4 2019. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Catalyst Capital Advisors held 30,550 shares of Medtronic worth $2.39M as of Q2 2026.
  • Catalyst Capital Advisors left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.04% of Catalyst Capital Advisors's portfolio in Q2 2026, its #104 holding.
  • Catalyst Capital Advisors first reported a position in Medtronic in Q2 2013 and has held it in 24 quarters since.
  • Catalyst Capital Advisors's Medtronic position peaked at $7.13M in Q4 2019.
  • 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Catalyst Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.